Data as of Nov 21
| +0.06 / +0.46%|
The 3 analysts offering 12-month price forecasts for Osiris Therapeutics Inc have a median target of 19.00, with a high estimate of 26.00 and a low estimate of 7.00. The median estimate represents a +44.82% increase from the last price of 13.12.
The current consensus among 3 polled investment analysts is to Buy stock in Osiris Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.